Advanced Micro Devices, Inc (NASDAQ:AMD) shares rebounded on Monday as investors assessed geopolitical risks, potential new U.S. export rules for AI chips, and the company’s latest product and licensing developments.

Export Policy And Geopolitical Risks Pressure The Chip Sector

AMD stock rebounded on Monday from last week’s lows amid a semiconductor and tech sector selloff spurred by new U.S. export policy discussions and geopolitical tensions tied to the U.S.–Israel conflict with Iran.

The stock lost 3.9% in market value between February 27 and March 6 compared to the PHLX Semiconductor Index’s 6.8%. The tech-heavy NASDAQ Composite Index lost 1.2%.

The Trump administration is reportedly considering a new framework to regulate exports of advanced AI chips from companies such as Nvidia Corp (NASDAQ:NVDA) and AMD.

Under the proposal, countries seeking large shipments—especially 200,000 chips or more—may need to invest in U.S.-based AI data centers or provide government-level security guarantees.

The draft rules could also require export licenses for smaller installations, monitor chip usage, and impose software restrictions to prevent chips from being linked to large computing clusters.

Meanwhile, rising tensions in the U.S.–Iran conflict are increasing concerns about potential disruptions to semiconductor supply chains.

AMD Expands Edge AI Processor Portfolio

AMD is also expanding its Ryzen AI Embedded P100 Series processor lineup to support the growing demand for real-time AI computing in industrial automation, robotics, and other edge AI applications.

The new processors deliver up to twice the CPU core counts, up to eight times higher GPU compute, and about 36% higher system tera operations, designed for always-on environments that require real-time AI processing and reliable performance.

The chips feature eight to 12 “Zen 5” cores, up to 80 system TOPS for AI acceleration, RDNA 3.5 graphics, and an XDNA 2-based neural processing unit, combining CPU, GPU, and AI processing on a single chip.

AMD said the processors target industrial PCs, autonomous robots, and medical imaging systems, enabling workloads such as machine vision, robot navigation, and edge-based healthcare imaging.

The P100 Series processors are currently sampling, with four- to six-core versions expected to enter production in the second quarter of 2026 and eight- to 12-core versions expected to ship in July 2026.

Licensing Deal With Adeia Resolves Litigation

Separately, Adeia Inc (NASDAQ:ADEA) signed a multi-year licensing agreement with AMD that grants AMD access to Adeia’s semiconductor intellectual property portfolio.

The agreement also resolves all ongoing litigation between the two companies, allowing both sides to move forward while potentially exploring future collaboration on advanced semiconductor technologies.

Adeia said its IP portfolio includes technologies related to hybrid bonding, semiconductor packaging, and semiconductor processing, which it licenses to major semiconductor companies worldwide.

AMD Price Action: Advanced Micro Devices shares were up 2.57% at $197.38 at the time of publication on Monday, according to Benzinga Pro data.

Image Via Shutterstock